& Cancer Immunotherapies
These advances and cost reductions in genomics have paved the way for the development of precision medicine: treatments tailored to the unique genetic profile of patients. VP of Genomic Health at 23andme, Noura Abul-husn, states that “the push of people seeking genetic information on their own is a driving force behind personalized medicine,” something unimaginable only 20 years ago when the first project to sequence the human genome was finally completed. Unlike traditional approaches, as Sadik Kassim, CTO of Genomic Medicines at Danaher tells us, personalized medicine helps to “identify the mutations that could cause diseases, and intervene with maximum precision and swiftness to correct or modify the genetic cause." This opens doors for medical professionals to design treatments that are more effective and less toxic.